SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2432Disappointing result and $6 drop! ViroPharma Reports Results of Phase 3 Clinicalmlkr-2/9/2009
2431There's another phase III (liver transplant) with a non-inferiority endpointidos-2/9/2009
2430The drug may be toast, but the company is not. They paid, I think, over $400 mifred hayes-2/9/2009
2429<reply> Just FYI. Medicare rates nurse homes. medicare.govkenhott-2/9/2009
2428Some miss! They did not beat placebo? I would think that means the drug is toaIRWIN JAMES FRANKEL-2/9/2009
2427How in the H*** did you find THIS thread to post THAT on? (You'll be gone bThe Dodgy Ticker-2/9/2009
2426ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrokenhott-2/9/2009
2425Maribavir misses all endpoints, sounds like. :-( (from headlines, haven't scaram(o)uche-2/9/2009
2424Dyax gets FDA panel recommendation on drug Wednesday February 4, 5:15 pm ET DyaxIRWIN JAMES FRANKEL-2/4/2009
2423FDA Grants Priority Review of a Supplemental Biologics License Application for CIRWIN JAMES FRANKEL-2/3/2009
2422Thomas: 1. These are just hints about how -- and under what conditions -- mariscaram(o)uche-1/26/2009
2421Interesting Data But What Does it Mean? Hi scaram(o)uche, Thanks for the info Thomas Kirwin-1/26/2009
2420PLoS Pathog. 2009 Jan;5(1):e1000275. Epub 2009 Jan 23. Viral Mimicry of Cdc2/Cyscaram(o)uche-1/26/2009
2419Virol J. 2009 Jan 21;6(1):9. Conserved retinoblastoma protein-binding motif in scaram(o)uche-1/23/2009
2418ViroPharma - Nothing To Sneeze At 12/29/2008 5:59 AM ET Shares of biotech compThomas Kirwin-1/3/2009
2417Well we'll have to agree to disagree. I think the days are numbered.rkrw-12/31/2008
2416>> vancocin generics are coming next year VPHM still has some rear-guard Biomaven-12/31/2008
2415John, that's for vancomycin not vancocin! But it seems likely vancocin generrkrw-12/31/2008
2414Akorn announces Vancocin approval: reuters.com After spiking to $2.99, VPHM shJohn Metcalf-12/31/2008
2413Gloves are off! I'd like to know what the story is with the initial leak frorkrw-12/18/2008
2412ViroPharma Files FOIA Complaint Seeking Administrative Record for Vancocin(R) ThIRWIN JAMES FRANKEL-12/18/2008
2411Akorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence RecommThomas Kirwin-12/16/2008
2410ViroPharma Provides Update on Vancocin(R) Dec 15, 2008 13:53:00 (ET) EXTON, Pasjemmeri-12/15/2008
2409ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) toThomas Kirwin-12/1/2008
2408ViroPharma adds 2nd drug Friday, November 28, 2008, Philadelphia Business JournThomas Kirwin-11/28/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News